For an academic vaccine developer like me, it is of utmost importance to build our research program with the support of a biotech company with which we have built a high level of confidence and trust. Communication has to be easy and transparent, and the delivery of our product has to be in purity and quantity as needed, so that the timing for starting a clinical trial matches our plans. This is exactly the experience I have with ExcellGene. In addition to it, as a science-driven company, they bring innovative and creative solutions to complex problems.
Prof. François Spertini, MD
Laboratory of Immunology and Allergy Chief Physician, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland